January 2002
Worldwide Biotech;Jan2002, Vol. 14 Issue 1, p6
Trade Publication
Reports that Conceptus Inc., developer of the non-incisional permanent birth control procedure Essure, has received clearance from Health Canada to market Essure in Canada in 2002.


Related Articles

  • CONCEPTUS REPORTS NET LOSS OF $8.1 MILLION FOR 3RD QTR.  // Biotech Financial Reports;Jan2003, p1 

    Reports that Conceptus Inc., San Carlos, California-based developer of non-incisional permanent birth control procedure Essure, has announced its financial results for three and nine months ended September 30, 2002. Comparison of net loss per share reported by the company in 2002 with that in...

  • Egg stopper. Motluk, Alison // New Scientist;09/16/2000, Vol. 167 Issue 2256, p14 

    Reports on the development of a metal coil by Conceptus as a means of birth control. Insertion of the coil into the fallopian tubes; Other methods of permanent birth control; Effectiveness of the methods; Expansion of the coil to fill the fallopian tube; Effectiveness of the method.

  • Canada approves new version of Essure.  // Medical Device Daily;12/10/2007, Vol. 11 Issue 223, p7 

    The article reports that the third-generation Essure permanent birth control system of Conceptus has been approved by Health Canada. The modification made on the Essure system include changes to the delivery that reduce the number of steps a physician is required to perform during a placement...

  • When It Comes to Permanent Birth Control, Both Men and Women Want to Avoid the Knife.  // Biomedical Market Newsletter;3/31/2011, p729 

    The article reports on the launch of a video campaign by Conceptus Inc. that uses humor to help illustrate why men are often reluctant to get a vasectomy. It says that the video depicts men watching footage of an actual and shows that there is an unease about the surgical producure. It notes...

  • Planned Parenthood approves female sterilization method.  // Contemporary Sexuality;May2004, Vol. 38 Issue 5, p9 

    This article reports that the Planned Parenthood Federation of America (PPFA) approved, as of 2004, the use of a permanent female sterilization procedure called Essure. Created by the Conceptus Inc., the procedure is an alternative to tubal ligation that will be made available to patients in...

  • Conceptus: a study in sector dynamics, looming competition. LONG, DON // Medical Device Daily;12/5/2008, Vol. 12 Issue 236, p1 

    The article features medical device manufacturer Conceptus and its Essure permanent sterilization microdevice. The company is focused entirely on developing Essure, which has been able to grow robustly and sees big chances for continued growth. The microdevice is inserted into the fallopian...

  • Product Briefs.  // Medical Device Daily;4/12/2012, Vol. 16 Issue 71, p9 

    The article offers information on Z Flex-270 steerable sheath for electrophysiology procedures from Boston Scientific and Essure nonsurgical permanent birth control procedure from Conceptus.

  • Conceptus reduces field sales workforce by 15%.  // Medical Device Daily;1/10/2012, Vol. 16 Issue 6, p6 

    The article reports on the decision of Conceptus, the developer of Essure, a non-surgical permanent birth control method, to reduce its field sales workforce in the U.S. by around 15%. The downsizing is aimed at addressing a more efficient redeployment of its efforts to grow its Essure business....

  • An update on hysteroscopic tubal sterilization. Simon, Howard // Contemporary OB/GYN;Aug2006, Vol. 51 Issue 8, p42 

    The article provides information on hysteroscopic tubal sterilization. The Essure coil, which is the unique hysteroscopically-delivered tubal occlusion device manufactured by Conceptus Inc., was approved by the U.S. Food and Drug Administration in 2002 and has been used in over 45,000 Essure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics